Immune Checkpoint Pathway Expression in Lymphocyte Subpopulations in Patients with Common Variable Immunodeficiency
Paulina Mertowska1, Sebastian Mertowski1, Konrad Smolak1
1Department of Experimental Immunology, Medical University of Lublin, 20-093 Lublin, Poland.
Insights
This study reveals significant immune checkpoint molecule alterations in chronic lymphocytic leukemia (CLL) and common variable immunodeficiency (CVID) patients. These findings offer insights for improved diagnostics and personalized therapies for these immune and blood disorders.
Area of Science:
- Immunology
- Hematology
- Oncology
Background:
- Chronic lymphocytic leukemia (CLL) and common variable immunodeficiency (CVID) are distinct conditions involving immune system dysregulation.
- Immune checkpoint pathways play crucial roles in immune homeostasis and are implicated in various diseases.
Purpose of the Study:
- To investigate immune checkpoint molecule expression (PD-1/PD-L1, CTLA-4/CD86, CD200R/CD200) on lymphocyte subpopulations in CLL and CVID.
- To compare these expression levels with healthy controls and between the two disease groups.
Main Methods:
- Flow cytometry was used to analyze the percentage of immune checkpoint molecules and their ligands on peripheral blood lymphocyte subpopulations.
- Enzyme immunoassay tests were conducted to determine the serum concentrations of these soluble molecules.
Main Results:
- Significant alterations in the percentage of tested immune checkpoint molecules were observed on T and B lymphocyte subpopulations in both CLL and CVID patients compared to healthy volunteers.
- Expression differences were also noted between CLL and CVID patient groups.
- Serum concentrations of soluble immune checkpoint molecules corroborated the flow cytometry findings.
Conclusions:
- The study highlights significant immune checkpoint pathway dysregulation in CLL and CVID.
- These findings may contribute to developing novel diagnostic and therapeutic strategies for these conditions.
- Understanding these pathways can aid in monitoring immune status and improving patient care for immunodeficiencies and hematological malignancies.
Abstract:
This study aims to gain a deeper understanding of chronic lymphocytic leukemia (CLL) and common variable immunodeficiency (CVID) by studying immune cells and specific immune checkpoint signaling pathways. The analysis of the percentage of selected immune points and their ligands (PD-1/PD-L1, CTLA-4/CD86, and CD200R/CD200) on peripheral blood lymphocyte subpopulations was performed using flow cytometry, and additional analyses determining the serum concentration of the above-mentioned molecules were performed using enzyme immunoassay tests. The obtained results indicate several significant changes in the percentage of almost all tested molecules on selected subpopulations of T and B lymphocytes in both CVID and CLL patients in relation to healthy volunteers and between the disease subunits themselves. The results obtained were also supported by the analysis of the serum concentration of soluble molecules tested. By uncovering valuable insights, we hope to enhance our comprehension and management of these conditions, considering both immunodeficiencies and hematological malignancies. Understanding the role of these signaling pathways in disease development and progression may lead to the development of modern, personalized diagnostic and therapeutic strategies. Ultimately, this knowledge may enable the monitoring of the immune system in patients with CVID and CLL, paving the way for improved patient care in the future.
More Related Videos
07:17Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice
Published on: June 22, 2016
12:36Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry
Published on: June 26, 2018
